Two Sigma Advisers’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-213,000
| Closed | -$456K | – | 2476 |
|
|
2025
Q1 | $456K | Sell |
213,000
-28,400
| -12% | -$60.8K | ﹤0.01% | 1820 |
|
|
2024
Q4 | $584K | Sell |
241,400
-14,200
| -6% | -$34.4K | ﹤0.01% | 1724 |
|
|
2024
Q3 | $624K | Sell |
255,600
-3,500
| -1% | -$8.54K | ﹤0.01% | 1615 |
|
|
2024
Q2 | $666K | Sell |
259,100
-4,400
| -2% | -$11.3K | ﹤0.01% | 1761 |
|
|
2024
Q1 | $769K | Sell |
263,500
-20,100
| -7% | -$58.7K | ﹤0.01% | 1688 |
|
|
2023
Q4 | $655K | Buy |
283,600
+118,000
| +71% | +$273K | ﹤0.01% | 1813 |
|
|
2023
Q3 | $432K | Sell |
165,600
-25,000
| -13% | -$65.3K | ﹤0.01% | 1842 |
|
|
2023
Q2 | $682K | Sell |
190,600
-254,300
| -57% | -$910K | ﹤0.01% | 1692 |
|
|
2023
Q1 | $970K | Buy |
444,900
+193,000
| +77% | +$421K | ﹤0.01% | 1646 |
|
|
2022
Q4 | $3.03M | Sell |
251,900
-79,600
| -24% | -$958K | 0.01% | 1009 |
|
|
2022
Q3 | $2.15M | Sell |
331,500
-350,300
| -51% | -$2.27M | 0.01% | 1137 |
|
|
2022
Q2 | $3.12M | Buy |
681,800
+19,800
| +3% | +$90.7K | 0.01% | 980 |
|
|
2022
Q1 | $5.73M | Buy |
662,000
+434,700
| +191% | +$3.76M | 0.02% | 745 |
|
|
2021
Q4 | $3.25M | Buy |
+227,300
| New | +$3.25M | 0.01% | 959 |
|